{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:30:57Z","timestamp":1784770257544,"version":"3.55.0"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T00:00:00Z","timestamp":1696636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.thromres.2023.10.006","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T11:10:27Z","timestamp":1696677027000},"page":"76-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study"],"prefix":"10.1016","volume":"231","author":[{"given":"Tommaso","family":"Bucci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.J.","family":"Ames","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Cammisotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cardamone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ciampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Mangoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Carnevale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Pastori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.thromres.2023.10.006_bb0005","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.006_bb0010","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/rheumatology\/keh722","article-title":"Antiphospholipid antibodies are associated with enhanced oxidative stress, decreased plasma nitric oxide and paraoxonase activity in an experimental mouse model","volume":"44","author":"Delgado Alves","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.thromres.2023.10.006_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2021.102821","article-title":"Isoprostanes in systemic lupus erythematosus and antiphospholipid syndrome: a systematic review and meta-analysis","volume":"20","author":"Merashli","year":"2021","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.thromres.2023.10.006_bb0020","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1055\/s-0038-1648840","article-title":"Prevalence, follow-up and clinical significance of the anticardiolipin antibodies in normal subjects","volume":"72","author":"Vila","year":"1994","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.006_bb0025","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2005-03-1319","article-title":"Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor","volume":"106","author":"Fischetti","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2023.10.006_bb0030","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1016\/j.jacc.2017.02.058","article-title":"Antiphospholipid syndrome: role of vascular endothelial cells and implications for risk stratification and targeted therapeutics","volume":"69","author":"Corban","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2023.10.006_bb0035","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/ard.2006.065037","article-title":"Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies","volume":"66","author":"Pierangeli","year":"2007","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2023.10.006_bb0040","doi-asserted-by":"crossref","first-page":"9605894","DOI":"10.1155\/2017\/9605894","article-title":"Toll-like receptor 4 signalling and its impact on platelet function, thrombosis, and haemostasis","volume":"2017","author":"Vallance","year":"2017","journal-title":"Mediat. Inflamm."},{"key":"10.1016\/j.thromres.2023.10.006_bb0045","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1136\/ard.2003.014175","article-title":"Antiphospholipid syndrome associated with infections: clinical and microbiological characteristics of 100 patients","volume":"63","author":"Cervera","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2023.10.006_bb0050","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41569-022-00737-2","article-title":"Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease","volume":"20","author":"Violi","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.thromres.2023.10.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102832","article-title":"Proprotein convertase subtilisin\/kexin type 9 (PCSK9) levels in primary antiphospholipid syndrome. The multicenter ATHERO-APS study","volume":"129","author":"Bucci","year":"2022","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.thromres.2023.10.006_bb0060","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.thromres.2021.12.001","article-title":"Cardiac and vascular features of arterial and venous primary antiphospholipid syndrome. The multicenter ATHERO-APS study","volume":"209","author":"Bucci","year":"2022","journal-title":"Thromb. Res."},{"key":"10.1016\/j.thromres.2023.10.006_bb0065","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1093\/eurheartj\/ehz687","volume":"40","author":"Grant","year":"2019","journal-title":"Eur. Heart J."},{"issue":"36","key":"10.1016\/j.thromres.2023.10.006_bb0070","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1097\/HJH.0000000000001940","volume":"2018","author":"Williams","year":"2018","journal-title":"J. Hypertens."},{"key":"10.1016\/j.thromres.2023.10.006_bb0075","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ejhf.2333","volume":"24","author":"M. Authors\/Task Force","year":"2022","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.thromres.2023.10.006_bb0080","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.006_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203494","article-title":"Anticardiolipin (aCL) in sera from periodontitis subjects activate toll-like receptor 4 (TLR4)","volume":"13","author":"Schenkein","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.thromres.2023.10.006_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.779503","article-title":"Circulating lipopolysaccharides and impaired antioxidant status in patients with atrial fibrillation. Data from the ATHERO-AF study","volume":"8","author":"Menichelli","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.thromres.2023.10.006_bb0095","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.semarthrit.2019.04.009","article-title":"The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: results from the APS ACTION cohort","volume":"49","author":"Radin","year":"2019","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.thromres.2023.10.006_bb0100","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/rheumatology\/kex466","article-title":"Clinical utility of the global anti-phospholipid syndrome score for risk stratification: a pooled analysis","volume":"57","author":"Sciascia","year":"2018","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.thromres.2023.10.006_bb0105","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cardiores.2006.09.012","article-title":"Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells","volume":"72","author":"Park","year":"2006","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.thromres.2023.10.006_bb0110","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/325481","article-title":"Propofol reduces lipopolysaccharide-induced, NADPH oxidase (NOX 2) mediated TNF-alpha and IL-6 production in macrophages","volume":"2013","author":"Meng","year":"2013","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.thromres.2023.10.006_bb0115","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1160\/TH16-11-0857","article-title":"Lipopolysaccharide as trigger of platelet aggregation via eicosanoid over-production","volume":"117","author":"Nocella","year":"2017","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.006_bb0120","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1007\/s11745-016-4198-x","article-title":"Assessment of isoprostanes in human plasma: technical considerations and the use of mass spectrometry","volume":"51","author":"Lee","year":"2016","journal-title":"Lipids"},{"key":"10.1016\/j.thromres.2023.10.006_bb0125","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.3899\/jrheum.100494","article-title":"Clinical relevance of nitric oxide metabolites and nitrative stress in thrombotic primary antiphospholipid syndrome","volume":"37","author":"Ames","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.thromres.2023.10.006_bb0130","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1161\/CIRCULATIONAHA.117.032901","article-title":"Nitric oxide signaling and atherothrombosis redux: evidence from experiments of nature and implications for therapy","volume":"137","author":"Loscalzo","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.thromres.2023.10.006_bb0135","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0735-1097(99)00448-9","article-title":"Association of endotoxemia with carotid atherosclerosis and cardiovascular disease: prospective results from the Bruneck study","volume":"34","author":"Wiedermann","year":"1999","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.thromres.2023.10.006_bb0140","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1093\/eurheartj\/ehz893","article-title":"Low-grade endotoxaemia enhances artery thrombus growth via toll-like receptor 4: implication for myocardial infarction","volume":"41","author":"Carnevale","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.thromres.2023.10.006_bb0145","first-page":"6","article-title":"Gut-derived serum lipopolysaccharide is associated with enhanced risk of major adverse cardiovascular events in atrial fibrillation: effect of adherence to mediterranean diet","author":"Pastori","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.thromres.2023.10.006_bb0150","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1152\/ajpgi.00098.2016","article-title":"Gastrointestinal and hepatic mechanisms limiting entry and dissemination of lipopolysaccharide into the systemic circulation","volume":"311","author":"Guerville","year":"2016","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.thromres.2023.10.006_bb0155","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.aad0135","article-title":"A gut-vascular barrier controls the systemic dissemination of bacteria","volume":"350","author":"Spadoni","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.thromres.2023.10.006_bb0160","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1160\/TH14-07-0628","article-title":"Cofactor-independent antiphospholipid antibodies activate the NLRP3-inflammasome via endosomal NADPH-oxidase: implications for the antiphospholipid syndrome","volume":"113","author":"Muller-Calleja","year":"2015","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.thromres.2023.10.006_bb0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.585146","article-title":"Lipopolysaccharide recognition in the crossroads of TLR4 and caspase-4\/11 mediated inflammatory pathways","volume":"11","author":"Zamyatina","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.thromres.2023.10.006_bb0170","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.freeradbiomed.2022.03.019","article-title":"Oxidative stress in the pathophysiology of type 2 diabetes and related complications: current therapeutics strategies and future perspectives","volume":"184","author":"Bhatti","year":"2022","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.thromres.2023.10.006_bb0175","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1016\/j.semarthrit.2020.08.012","article-title":"Antiphospholipid antibodies and lower extremity peripheral artery disease: a systematic review and meta-analysis","volume":"50","author":"Merashli","year":"2020","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.thromres.2023.10.006_bb0180","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.autrev.2019.03.005","article-title":"Immunoglobulin G (IgG) anticardiolipin antibodies and recurrent cardiovascular events. A systematic review and Bayesian meta-regression analysis","volume":"18","author":"Pastori","year":"2019","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.thromres.2023.10.006_bb0185","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.vph.2012.02.004","article-title":"Nitric oxide synthase uncoupling: a therapeutic target in cardiovascular diseases","volume":"57","author":"Roe","year":"2012","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.thromres.2023.10.006_bb0190","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1093\/rheumatology\/keab410","article-title":"Effect of statins on the prevention of recurrent thrombosis in thrombotic antiphospholipid syndrome","volume":"61","author":"Kwon","year":"2022","journal-title":"Rheumatology (Oxford)"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384823002839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:51:34Z","timestamp":1758736294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384823002839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":38,"alternative-id":["S0049384823002839"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.006","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-grade endotoxemia and risk of recurrent thrombosis in primary antiphospholipid syndrome. The multicenter ATHERO-APS study","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2023.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}